NO20090663L - Fremgangsmate for fremstilling av insulinanaloger som har en dibasisk B-kjede terminus - Google Patents

Fremgangsmate for fremstilling av insulinanaloger som har en dibasisk B-kjede terminus

Info

Publication number
NO20090663L
NO20090663L NO20090663A NO20090663A NO20090663L NO 20090663 L NO20090663 L NO 20090663L NO 20090663 A NO20090663 A NO 20090663A NO 20090663 A NO20090663 A NO 20090663A NO 20090663 L NO20090663 L NO 20090663L
Authority
NO
Norway
Prior art keywords
dibasic
insulin analogues
chain terminus
preparing insulin
precursor
Prior art date
Application number
NO20090663A
Other languages
English (en)
Inventor
Frank Zocher
Paul Habermann
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20090663L publication Critical patent/NO20090663L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen angår en fremgangsmåte for fremstilling av en type insulin ved genetisk modifisering av en forløper derav og omdanner nevnte forløper til det respektive insulinet i en enzymkatalysert ligasjonsreaksjon med lysinamid eller argininamid, eller med lysin eller arginin som er modifisert med beskyttende grupper, og eventuelt etterfølgende hydrolyse.
NO20090663A 2006-07-11 2009-02-11 Fremgangsmate for fremstilling av insulinanaloger som har en dibasisk B-kjede terminus NO20090663L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006031955A DE102006031955A1 (de) 2006-07-11 2006-07-11 Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
PCT/EP2007/005933 WO2008006497A1 (de) 2006-07-11 2007-07-05 Verfahren zur herstellung von insulinanaloga mit dibasischem b-kettenende

Publications (1)

Publication Number Publication Date
NO20090663L true NO20090663L (no) 2009-02-11

Family

ID=38468893

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090663A NO20090663L (no) 2006-07-11 2009-02-11 Fremgangsmate for fremstilling av insulinanaloger som har en dibasisk B-kjede terminus

Country Status (19)

Country Link
US (1) US8410048B2 (no)
EP (1) EP2041170B1 (no)
JP (1) JP5331685B2 (no)
KR (1) KR101439110B1 (no)
CN (1) CN101490082B (no)
AR (1) AR061865A1 (no)
AU (1) AU2007272057B2 (no)
BR (1) BRPI0714297A2 (no)
CA (1) CA2657041C (no)
DE (1) DE102006031955A1 (no)
DK (1) DK2041170T3 (no)
ES (1) ES2423684T3 (no)
IL (1) IL196360A (no)
MX (1) MX2009000275A (no)
MY (1) MY148984A (no)
NO (1) NO20090663L (no)
PT (1) PT2041170E (no)
TW (1) TWI440717B (no)
WO (1) WO2008006497A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005046113A1 (de) * 2005-09-27 2007-03-29 Sanofi-Aventis Deutschland Gmbh Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen
BRPI0820535B8 (pt) 2007-11-16 2021-05-25 Novo Nordisk As composições farmacêuticas contendo insulina e um peptídeo insulinotrópico
RU2495131C2 (ru) * 2008-02-19 2013-10-10 Байокон Лимитид Способ получения рекомбинантного инсулина гларгина
JP2013535467A (ja) * 2010-07-28 2013-09-12 スマートセルズ・インコーポレイテツド 組換えにより発現されたインスリンポリペプチドおよびその使用
WO2013015697A1 (en) 2011-07-28 2013-01-31 Mabion S.A. A recombinant protein, a polynucleotide encoding it as well as a method of obtaining insulin or its an analogue
CN102504022A (zh) * 2011-11-30 2012-06-20 苏州元基生物技术有限公司 含有保护赖氨酸的胰岛素原及使用其制备胰岛素的方法
PL233560B1 (pl) 2014-12-05 2019-10-31 Mabion Spolka Akcyjna Sposób otrzymywania insuliny lub analogu insuliny z prekursora rekombinowanego białka

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55138393A (en) * 1979-04-13 1980-10-29 Shionogi & Co Ltd Semisynthesis of insulin
DE3326473A1 (de) 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DE3636903A1 (de) 1985-12-21 1987-07-02 Hoechst Ag Fusionsproteine mit eukaryotischem ballastanteil
GB8618152D0 (en) * 1986-07-25 1986-09-03 Renishaw Plc Co-ordinate measuring
EP0294851A3 (de) * 1987-06-12 1990-05-09 Berlin-Chemie Ag Verfahren zur Herstellung von Humaninsulin und seinen Derivaten
US6875589B1 (en) * 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DE3844211A1 (de) 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5227293A (en) 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
DE4405179A1 (de) 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
DE10108100A1 (de) 2001-02-20 2002-08-29 Aventis Pharma Gmbh Verwendung supersekretierbarer Peptide in Verfahren zu deren Herstellung und paralleler Verbesserung der Exportate eines oder mehrerer anderer Polypeptide von Interesse
DE10108211A1 (de) 2001-02-20 2002-08-22 Aventis Pharma Gmbh Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen
DE10108212A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände
DE60236014D1 (de) * 2001-11-19 2010-05-27 Novo Nordisk As Verfahren zur herstellung von insulinverbindungen
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
WO2004005342A1 (en) 2002-07-04 2004-01-15 Zealand Pharma A/S Glp-1 and methods for treating diabetes
ES2309785T3 (es) 2004-08-13 2008-12-16 F. Hoffmann-La Roche Ag Modificacion c-terminal de polipeptidos.
DE102004058306A1 (de) 2004-12-01 2006-07-27 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden
DE102005046113A1 (de) * 2005-09-27 2007-03-29 Sanofi-Aventis Deutschland Gmbh Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen

Also Published As

Publication number Publication date
JP5331685B2 (ja) 2013-10-30
MY148984A (en) 2013-06-28
DE102006031955A1 (de) 2008-01-17
US8410048B2 (en) 2013-04-02
BRPI0714297A2 (pt) 2013-02-26
WO2008006497A1 (de) 2008-01-17
US20090192073A1 (en) 2009-07-30
EP2041170B1 (de) 2013-05-01
KR20090038868A (ko) 2009-04-21
CN101490082B (zh) 2013-08-14
DK2041170T3 (da) 2013-08-05
AR061865A1 (es) 2008-09-24
KR101439110B1 (ko) 2014-09-12
CA2657041A1 (en) 2008-01-17
EP2041170A1 (de) 2009-04-01
CN101490082A (zh) 2009-07-22
HK1130815A1 (en) 2010-01-08
JP2009542235A (ja) 2009-12-03
AU2007272057B2 (en) 2012-06-14
ES2423684T3 (es) 2013-09-23
PT2041170E (pt) 2013-07-18
TWI440717B (zh) 2014-06-11
AU2007272057A1 (en) 2008-01-17
CA2657041C (en) 2016-04-26
TW200817511A (en) 2008-04-16
IL196360A0 (en) 2011-08-01
MX2009000275A (es) 2009-01-26
IL196360A (en) 2015-08-31

Similar Documents

Publication Publication Date Title
NO20090663L (no) Fremgangsmate for fremstilling av insulinanaloger som har en dibasisk B-kjede terminus
WO2010104391A3 (en) Preparation of adipic acid
EP2558584A4 (en) PROCESS FOR PRODUCING FERMENTATION PRODUCTS
WO2013093760A3 (en) Compositions, methods, and kits for preparing sialylated recombinant proteins
PH12012500510A1 (en) Method for the enzymatic production of 3-hydroxy-s-methylbutyric acid from acetone and acetyl-coa
MX353884B (es) Produccion de alquenos a traves de la conversion enzimatica combinada de acidos 3-hidroxialcanoicos.
EP2379748A4 (en) MULTIBASE RELEASE FOR LONG READINGS IN SEQUENCING BY SYNTHESIS PROTOCOLS
WO2012027282A3 (en) Recombinant lignocellulose degradation enzymes for the production of soluble sugars from cellulosic biomass
WO2012019175A8 (en) Production of malonyl-coa derived products via anaerobic pathways
EP3708581A3 (en) A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
ATE541033T1 (de) Verfahren zur herstellung von cellulase und hemicellulase mit hoher hydrolyseaktivität
WO2011106368A3 (en) Amplification methods to minimise sequence specific bias
WO2010122367A3 (en) Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
IN2014DN10709A (no)
WO2010101359A3 (ko) Ｌ-아미노산 생산 미생물 및 이를 이용한 ｌ-아미노산 생산 방법
BRPI0916147A8 (pt) Cepa de saccharomyces ap., método para a produção de um produto de fermentação e massa celular, e, uso da cepa de saccharomyces sp.
PH12014501161A1 (en) Biotechnological production of 3-hydroxyisobutyric acid
MY169376A (en) Method for producing levulinic acid from lignocellulosic biomass
MY151183A (en) Processes for the preparation of 4-oxo-octahydro-indole-1-carbocyclic acid methyl ester and derivatives thereof
WO2010005235A3 (ko) 효소 전환반응을 이용한 광학순수형 락티드 제조방법
EA201170477A1 (ru) СПОСОБ СИНТЕЗА (Aib)hGLP-1(7-36)-NH
WO2010101360A3 (ko) Ｌ-아미노산 생산 미생물 및 이를 이용한 ｌ-아미노산 생산 방법
SG194703A1 (en) Multistage cellulose hydrolysis and quench with or without acid
NZ590011A (en) Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
IN2015DN03312A (no)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application